Retrospective analysis of hyperlipidemia management in a transplant population

Pharmacotherapy

Volumn 25, Issue 7, 2005, Pages 918-923

  Schonder, Kristine S ^a,b   McKaveney, Teresa P ^a   Lynch, Kevin J ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c PFIZER INC   (United States)

Author keywords

Hyperlipidemia; LDL; Low density lipoprotein cholesterol; NCEP guidelines; Total cholesterol; Transplant; Transplantation

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ATORVASTATIN; AZATHIOPRINE; BILE ACID SEQUESTRANT; CERIVASTATIN; CHOLESTEROL; COLESTYRAMINE; CORTICOSTEROID; CYCLOSPORIN; FENOFIBRATE; FIBRIC ACID DERIVATIVE; FLUINDOSTATIN; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINIC ACID; ORAL ANTIDIABETIC AGENT; PRAVASTATIN; RAPAMYCIN; SIMVASTATIN; STATINE DERIVATIVE; TACROLIMUS;

ADULT; AGED; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; KIDNEY TRANSPLANTATION; LIPID BLOOD LEVEL; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; PATIENT MONITORING; PRACTICE GUIDELINE; PREVALENCE; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTILIPEMIC AGENTS; CHOLESTEROL; COMORBIDITY; FEMALE; GUIDELINE ADHERENCE; HOSPITALS, UNIVERSITY; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PRACTICE GUIDELINES; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 21444448246     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.2005.25.7.918     Document Type: Review

References (9)

1. Wheeler DC, Steiger J. Evolution and etiology of cardiovascular diseases in renal transplant recipients. Transplantation 2000;70(11 suppl):S41-5.
2. Kasiske BL. Hyperlipidemia in patients with chronic renal disease. Am J Kidney Dis 1998;32(suppl 3):S142-56.
3. Jindal RM, Sidner RA, Hughes D, Pescovitz MD. Metabolic problems in recipients of liver transplants. Clin Transplant 1996;10:213-17.
4. Ballantyne CM, Radovancevic B, Farmer JA, et al. Hyperlipidemia after heart transplantation: report of a 6-year experience with treatment recommendations. J Am Coll Cardiol 1992;19:1315-21.
5. Guijarro C, Massy ZA, Kasiske BL. Clinical correlation between renal allograft failure and hyperlipidemia. Kidney Int 1995;48(suppl 52):S56-9.
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Second report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II). Circulation 1994;89:1331-63.
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III), final report. Bethesda, MD: National Heart, Lung, and Blood Institute, Public Health Service, Department of Health and Human Services, 2002.
8. Malach M, Quinley J, Impertato PJ, Wallen M. Improving lipid evaluation and management in Medicare patients hospitalized for acute myocardial infarction. Arch Intern Med 2001; 161:839-44.
9. Kobashigawa J, Kasiske B. Hyperlipidemia in solid organ transplantation. Transplantation 1997;63:331-8.